| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $3.2M | +23.2% | +157.5% |
| SG&A Expense | $1.4M | -15.4% | +49.3% |
| Operating Income | -$4.6M | -8.1% | -110.6% |
| Income Tax | $0 | — | — |
| Net Income | -$4.9M | -13.6% | -109.2% |
| EPS (Basic) | -$5.82 | -13.5% | -3537.5% |
| EPS (Diluted) | -$5.82 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $2.8M | -61.5% | +51.2% |
| Current Assets | $4.8M | -42.4% | +31.5% |
| Total Assets | $5.2M | -36.8% | +32.8% |
| Current Liabilities | $3.0M | +89.6% | +29.9% |
| Total Liabilities | $3.8M | +79.4% | +66.4% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$11.4M | — | — |
| Capital Expenditures | $21K | — | — |
| Investing Cash Flow | -$21K | — | — |
| Financing Cash Flow | $8.4M | — | — |
| Free Cash Flow | -$11.4M | — | — |
| -3537.5% |
| $1.4M |
| -76.8% |
| -13.7% |